Giorgio Ciprandi
Ciprandi, Giorgio
VIAF ID: 240415263 (Personal)
Permalink: http://viaf.org/viaf/240415263
Preferred Forms
-
- 100 0 _ ‡a Giorgio Ciprandi
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study. | |
The discovery and development of omalizumab for the treatment of asthma | |
Double-masked, randomized, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis | |
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents | |
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules | |
Emerging drugs for the treatment of perennial allergic rhinitis | |
Focus on the cetirizine use in clinical practice: a reappraisal 30 years later | |
Fractional Exhaled Nitric Oxide: A Potential Biomarker in Allergic Rhinitis? | |
Fractional exhaled nitric oxide, methacholine, or forced expiratory flow between 25% and 75%: What's better in the daily clinical practice? | |
High exhaled nitric oxide levels may predict bronchial reversibility in allergic children with asthma or rhinitis | |
HMGB1: A pleiotropic activity | |
HMGB1 in nasal inflammatory diseases: a reappraisal 30 years after its discovery | |
Immunoregulatory Role of HLA-G in Allergic Diseases | |
The impact of gender on asthma in the daily clinical practice. | |
Improvement of clinical and immunopathologic parameters in asthmatic children treated for concomitant chronic rhinosinusitis | |
Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report | |
Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies | |
Inflammation Markers and FEF25-75: A Relevant Link in Children With Asthma | |
Inflammatory biomarkers for asthma endotyping and consequent personalized therapy. | |
Is Adenoidectomy Preventable? | |
Local Bacteriotherapy - a promising preventive tool in recurrent respiratory infections | |
Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment | |
The lower airway pathology of rhinitis | |
Measuring the perception of symptom, drug use and allergen immunotherapy efficacy using the Visual Analogue Scale | |
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge. | |
A multicomponent nutraceutical (<i>Perilla frutescens</i>, quercetin, and vitamin D3) as add-on therapy in patients with grass pollen-induced mild persistent asthma and rhinitis | |
Nasal cytology: a Precision Medicine tool in clinical practice. | |
Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis | |
Nasal obstruction is the key symptom in hay fever patients | |
New approaches for identifying and testing potential new anti-asthma agents. | |
Novel therapeutic interventions for allergic rhinitis | |
Paediatric emergency department visits fell by more than 70% during the COVID-19 lockdown in Northern Italy | |
Passive Exposure to Smoke Results in Defective Interferon-γ Production by Adenoids in Children With Recurrent Respiratory Infections | |
A pathophysiological approach for FeNO: A biomarker for asthma. | |
Pentraxin 3 and D-dimer in children with asthma: A real-world study | |
Perception of bronchodilation assessed by Visual Analogue Scale in children with asthma | |
A Pitfall to Avoid When Using an Allergen Microarray: The Incidental Detection of IgE to Unexpected Allergens | |
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II | |
Polysensitization as a challenge for the allergist: the suggestions provided by the Polysensitization Impact on Allergen Immunotherapy studies | |
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach | |
The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting | |
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors | |
Quality of life and polysensitization in young men with intermittent asthma | |
Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions | |
The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis. | |
Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience | |
Role of adenoids and adenoiditis in children with allergy and otitis media | |
Role of FEF25%–75% as a predictor of bronchial hyperreactivity in allergic patients | |
Role of forced expiratory flow at 25–75% as an early marker of small airways impairment in subjects with allergic rhinitis | |
Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. | |
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) | |
Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care | |
Sensitization to nsLTP: A Retrospective Study in An Italian Pediatric Population over the Last Decade | |
Serum eosinophilic cationic protein: is there a role in respiratory disorders? | |
Serum leptin levels depend on allergen exposure in patients with seasonal allergic rhinitis. | |
Serum resistin in persistent allergic rhinitis: preliminary data in adults | |
Severe asthma in children: Current goals and unmet needs | |
Single-dose oral tolerance test with alternative compounds for the management of adverse reactions to drugs | |
Soluble HLA-G serum levels depend on allergy type and IgE levels | |
Special Issues for COVID-19 in Children and Adolescents | |
Sublingual immunotherapy: an update on immunologic and functional effects | |
Symptom perception and asthma control. | |
Thirty-year survey on airborne pollen concentrations in Genoa, Italy: relationship with sensitizations, meteorological data, and air pollution | |
Tonsil volume and allergic rhinitis in children | |
Turbinate Hypertrophy, Allergic Rhinitis, and Otitis Media | |
Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease | |
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma | |
Visual analog scale for assessing the perception of short-acting β2-agonist use in clinical practice | |
Vitamin D status and body mass index in children with atopic dermatitis: A pilot study in Italian children. | |
Vitamin D3 in children with allergic asthma in clinical practice | |
What are the effects of rhinitis on patients with asthma? | |
What should drive the choice of allergen for immunotherapy in polysensitized patients? |